Nuclear medicine in hepatology.
نویسندگان
چکیده
منابع مشابه
History and Perspectives of Nuclear Medicine in Myanmar
Nuclear Medicine was established in Myanmar in 1963 by Dr Soe Myint and International Atomic Energy expert Dr R. Hochel at Yangon General Hospital. Nuclear medicine diagnostic and therapeutic services started with Probe Scintillation Detector Systems and rectilinear scanner. In the early stage, many Nuclear Medicine specialists from the International Atomic Energy Agency (IAEA) spent some time ...
متن کاملEditor-in-Chief’s welcome to Hepatology, Medicine and Policy
Hepatology, Medicine and Policy (HMAP), a new open-access peer-reviewed journal, is making its debut at a time when the hepatitis field is seeing great progress but still has far to go. The World Health Organization and many countries have shown increasing interest in viral hepatitis in recent years, helping to foster a stronger response to this group of diseases. Meanwhile, alcohol-associated ...
متن کاملHybrid Phantom Applications to Nuclear Medicine
Annually, many people are irradiated for diagnostic and therapeutic purposes. Assessment of radiation dose and its related risks to patients are important issues in radiation protection dosimetry. The complex mathematical calculations of the absorbed and effective doses are now done with computers. The calculations are performed with the help of anthropomorphic computational models of human bod...
متن کاملThe application of unconventional PET tracers in nuclear medicine
The production and application of PET tracers has been a unique step in the progress of nuclear medicine in last two decades. The most important PET tracers include F-18, C-11 and N-13 radioisotopes and many nuclear medicine centers throughout the globe are using them. However some new tracers are under their way to the mass administration, currently being in th...
متن کاملNew techniques in nuclear medicine for tumor detection [Persian]
Widespread studies on tumor diagnosis has led to the development of techniques with greater sensitivity and improved specificity for detection of occult and small subclinical tumors. Tumor imaging by radiolabeling of tumor-specific antibodies (Immunoscintigraphy) or tissue specific biochemical agents (Receptor imaging) and especially physiologic imaging with positron emitters (PET), have ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: RADIOISOTOPES
سال: 1988
ISSN: 1884-4111,0033-8303
DOI: 10.3769/radioisotopes.37.5_295